Studies related to Liver Fat and Trimethylglycine

Betaine, A Promising New Agent For Patients With Nonalcoholic Steatohepatitis: Results Of A Pilot Study

Effect Decrease
Trial Design Cohort
Trial Length 6+ Months
Number of Subjects 7
Sex Both Genders
Age Range 30-44, 45-64
Body Types Overweight
Notes for this study:
Supplementation of betaine at 500mg twice daily over the course of one year was able to fully normalize liver enzymes in three out of seven patients and reduce them by more than 50% in three others, with one nonresponder and the dropouts (before the year the trial lasted) also noting a 38-39% reduction.

Full details on all 3 studies are available to Examine members — try free for 14 days.

Already a member? Log in now to access.